Pfizer expects to produce 80 mn courses of Covid-19 antiviral pill: Report
Earlier this month, Pfizer said it expects to manufacture 180,000 treatment courses by the end of this year and at least 50 mn courses by the end of next year, including 21 mn in the first half of 2022
COVID-19: Not sure whether vaccine will work against Variant of Concern' Omicron, says Pfizer
Pfizer promised to develop a new COVID-19 vaccine against the Omicron within 100 days.Moderna said it will develop a booster shot against the new Omicron variant of the coronavirus
Pfizer sues employee for allegedly stealing COVID vaccine secrets
In a complaint filed on Tuesday in San Diego federal court, Pfizer said Chun Xiao Li breached her confidentiality agreement by uploading more than 12,000 files without permission to her personal accounts.
Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received request for issue of duplicate Share Certificate(s) from the Shareholder(s).
Pfizer alleges departing employee stole confidential files, including Covid vaccine secrets
In its complaint Pfizer said Chun Xiao Li, an associate director of statistics, has misled Pfizer about what she took, how she took it, when and why she did it, and where those files and possibly others can be found. Canada approves Pfizer's Covid-19 vaccine for kids
Doses will be a third of the amount given to teens and adults
Canada to allow entry to those vaccinated with Sinopharm, Sinovac, Covaxin
Currently, Canada only accepts travellers who have received the vaccines, including Pfizer, Moderna, AstraZeneca and Johnson and Johnson
Pfizer signs $5.3-bn deal with US govt for 10 mn Covid-19 pills
The oral drug could be a promising new weapon in the fight against the pandemic PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholder(s):
Pfizer-BioNTech, Moderna jabs show better immunity
Research at Johns Hopkins Medicine has found immune cells existing even post six months